Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
Clinical trial NCT00311428 · COMPLETED
Trial details
- NCT number
- NCT00311428
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.